CIK 0001621221 · Non-accelerated filer<br>Smaller reporting company
ARTELO BIOSCIENCES, INC.
Sign in to watch- Ticker
- ARTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 331220924
- Phone
- 858-925-7049
- Business address
- 505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA, 92075
- Former names
- REACTIVE MEDICAL INC., KNIGHT KNOX DEVELOPMENT CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-28 | FAVORITO TAMARA A Director | Conversion · Warrant (right to buy) | +12,566 | 12,566 | ||
| 2025-10-28 | FAVORITO TAMARA A Director | Conversion · Convertible Promissory Note | +0 | $19,793.00 | $0 | |
| 2025-10-28 | Gorgas Gregory D. President, CEO, Treasurer, Sec | Conversion · Convertible Promissory Note | −0 | $35,000.00 | $0 | |
| 2025-10-28 | Gorgas Gregory D. President, CEO, Treasurer, Sec | Conversion · Warrant (right to buy) | +9,586 | 9,586 | ||
| 2025-10-28 | Gorgas Gregory D. President, CEO, Treasurer, Sec | Conversion · Warrant (right to buy) | +17,952 | 17,952 | ||
| 2025-10-28 | Gorgas Gregory D. President, CEO, Treasurer, Sec | Conversion · Convertible Promissory Note | +0 | $27,710.00 | $0 | |
| 2025-07-02 | Gorgas Gregory D. President, CEO, CFO, Treasurer | Grant or award · Stock Option (right to buy) | +20,393 | 20,393 | ||
| 2025-07-02 | Gorgas Gregory D. President, CEO, CFO, Treasurer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-05-01 | FAVORITO TAMARA A Director | Purchase · Convertible Promissory Note | +0 | $25,000.00 | $0 | |
| 2025-05-01 | MATSUI CONNIE Director | Purchase · Convertible Promissory Note | +0 | $140,000.00 | $0 | |
| 2025-05-01 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase · Convertible Promissory Note | +0 | $35,000.00 | $0 | |
| 2024-12-20 | MATSUI CONNIE Director | Grant or award · Stock Option (right to buy) | +1,750 | 1,750 | ||
| 2024-12-20 | Blayney Douglas Director | Grant or award · Stock Option (right to buy) | +1,750 | 1,750 | ||
| 2024-12-20 | Reyes Gregory Director | Grant or award · Stock Option (right to buy) | +1,750 | 1,750 | ||
| 2024-12-20 | EMANUELE ROBERT MARTIN Director | Grant or award · Stock Option (right to buy) | +1,750 | 1,750 | ||
| 2024-12-20 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +1,750 | 1,750 | ||
| 2024-12-20 | FAVORITO TAMARA A Director | Grant or award · Stock Option (right to buy) | +1,750 | 1,750 | ||
| 2024-02-28 | FAVORITO TAMARA A Director | Returned to the company · Stock Option (right to buy) | −2,000 | 0 | ||
| 2024-02-28 | FAVORITO TAMARA A Director | Returned to the company · Stock Option (right to buy) | −667 | 0 | ||
| 2024-02-28 | FAVORITO TAMARA A Director | Returned to the company · Stock Option (right to buy) | −667 | 0 |
Page 2 of 9 · 176 trades